Liqing Zheng，born in 1980，Ph.D., A.P., Master's Supervisor

Educational Background：

2010/09- 2013/07     Peking Union Medical College & Institute of Biomedical Engineering,Chinese Academy of Medical Sciences , PhD Candidate, Supervisor: Prof. Yingxin Li

2003/09- 2006/07     Hebei Medical University, College of Pharmacy, Master Degree, Supervisor: Prof. Danshen Zhang

1999/09- 2003/07     Hebei Medical University, College of Pharmacy, Bachelor Degree

Scientific Curriculum:
2013/09- Now           Hebei  North University,  College of Pharmacy, Associate Professor       
Published Work：  
1. Carrier cascade target delivery of 5-aminolevulinic acid nanoplatform to enhance antitumor efficiency of photodynamic therapy against lung cancer. Ze Li, Yuxuan Song, Qiang Luo, Zhenbao Liu, Yunqi Man, Jianhua Liu, Yuze Lu, Liqing Zheng*. Journal of Photochemistry & Photobiology, B: Biology. 2024, 112999.
2. A novel photosensitizer DTPP-mediated photodynamic therapy induces oxidative stress and apoptosis through mitochondrial pathways in LA795 cells. Liqing Zheng, Ze Li, Ruibo Wang, Jing Wang, Bochao Liu, Yiying Wang, Shihao Qin, Junying Yang, Jianhua Liu. Photodiagnosis Photodyn Ther. 2024, 45, 103894.
3. Design, Preparation, and Evaluation of Osthol Poly-Butyl-Cyanoacrylate Nanoparticles with Improved In Vitro Anticancer Activity in Neuroblastoma Treatment. Liqing Zheng, Ze Li, Lixia Shen, Jianhua Liu. Molecules 2022, 27, 6908.
4. The oxidative stress, mitochondrial pathway apoptosis, and the antagonistic effects of chrysophanol in SH-SY5Y cells via DTPP-induced photodynamic therapy. Liqing Zheng, Ze Li, Zhao Wang, Lixia Shen, Jianhua Liu. Photodiagnosis Photodyn Ther. 2022, 10, 103062.